Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery

2014 ◽  
Vol 133 (6) ◽  
pp. 1141-1144 ◽  
Author(s):  
Michael I. Meesters ◽  
Alexander B.A. Vonk ◽  
Emma K. van de Weerdt ◽  
Suzanne Kamminga ◽  
Christa Boer
Anaesthesia ◽  
2016 ◽  
Vol 71 (10) ◽  
pp. 1163-1168 ◽  
Author(s):  
M. I. Meesters ◽  
G. Kuiper ◽  
A. B. A. Vonk ◽  
S. A. Loer ◽  
C. Boer

Author(s):  
Wenyan Liu ◽  
Yang Yan ◽  
Dan Han ◽  
Yongxin Li ◽  
Qian Wang ◽  
...  

Abstract Background Systemic inflammation contributes to cardiac surgery–associated acute kidney injury (AKI). Cardiomyocytes and other organs experience hypothermia and hypoxia during cardiopulmonary bypass (CPB), which induces the secretion of cold-inducible RNA-binding protein (CIRP). Extracellular CIRP may induce a proinflammatory response. Materials and Methods The serum CIRP levels in 76 patients before and after cardiac surgery were determined to analyze the correlation between CIRP levels and CPB time. The risk factors for AKI after cardiac surgery and the in-hospital outcomes were also analyzed. Results The difference in the levels of CIRP (ΔCIRP) after and before surgery in patients who experienced cardioplegic arrest (CA) was 26-fold higher than those who did not, and 2.7-fold of those who experienced CPB without CA. The ΔCIRP levels were positively correlated with CPB time (r = 0.574, p < 0.001) and cross-clamp time (r = 0.54, p < 0.001). Multivariable analysis indicated that ΔCIRP (odds ratio: 1.003; 95% confidence interval: 1.000–1.006; p = 0.027) was an independent risk factor for postoperative AKI. Patients who underwent aortic dissection surgery had higher levels of CIRP and higher incidence of AKI than other patients. The incidence of AKI and duration of mechanical ventilation in patients whose serum CIRP levels more than 405 pg/mL were significantly higher than those less than 405 pg/mL (65.8 vs. 42.1%, p = 0.038; 23.1 ± 18.2 vs. 13.8 ± 9.2 hours, p = 0.007). Conclusion A large amount of CIRP was released during cardiac surgery. The secreted CIRP was associated with the increased risk of AKI after cardiac surgery.


Perfusion ◽  
2019 ◽  
Vol 35 (2) ◽  
pp. 138-144
Author(s):  
Helena Argiriadou ◽  
Polychronis Antonitsis ◽  
Anna Gkiouliava ◽  
Evangelia Papapostolou ◽  
Apostolos Deliopoulos ◽  
...  

Introduction: Cardiac surgery on conventional cardiopulmonary bypass induces a combination of thrombocytopenia and platelet dysfunction which is strongly related to postoperative bleeding. Minimal invasive extracorporeal circulation has been shown to preserve coagulation integrity, though effect on platelet function remains unclear. We aimed to prospectively investigate perioperative platelet function in a series of patients undergoing cardiac surgery on minimal invasive extracorporeal circulation using point-of-care testing. Methods: A total of 57 patients undergoing elective cardiac surgery on minimal invasive extracorporeal circulation were prospectively recruited. Anticoagulation strategy was based on individualized heparin management and heparin level–guided protamine titration performed in all patients with a specialized point-of-care device (Hemostasis Management System – HMS Plus; Medtronic, Minneapolis, MN, USA). Platelet function was evaluated with impedance aggregometry using the ROTEM platelet (TEM International GmbH, Munich, Germany). ADPtest and TRAPtest values were assessed before surgery and after cardiopulmonary bypass. Results: ADPtest value was preserved during surgery on minimal invasive extracorporeal circulation (58.2 ± 20 U vs. 53.6 ± 21 U; p = 0.1), while TRAPtest was found significantly increased (90 ± 27 U vs. 103 ± 38 U; p = 0.03). Postoperative ADPtest and TRAPtest values were inversely related to postoperative bleeding (correlation coefficient: −0.29; p = 0.03 for ADPtest and correlation coefficient: −0.28; p = 0.04 for TRAPtest). The preoperative use of P2Y12 inhibitors was identified as the only independent predictor of a low postoperative ADPtest value (OR = 15.3; p = 0.02). Conclusion: Cardiac surgery on minimal invasive extracorporeal circulation is a platelet preservation strategy, which contributes to the beneficial effect of minimal invasive extracorporeal circulation in coagulation integrity.


Perfusion ◽  
2020 ◽  
pp. 026765912094935
Author(s):  
Han Li ◽  
Cyril Serrick ◽  
Vivek Rao ◽  
Paul M Yip

Background: In cardiac surgery on cardiopulmonary bypass (CPB), heparin anticoagulation is monitored by point-of-care measurement of activated clotting time (ACT). The objective of this study was to compare four ACT systems in cardiac surgery in terms of their reproducibility, agreement and potential clinical impact at relevant medical decision points. Methods: The study included 40 cardiac surgery patients. Samples were taken at five time points before (T1), after heparinization for CPB (T2, T3, T4), and after heparin reversal (T5). The reproducibility, correlation, and differences in ACT values were assessed with two devices from each of the four ACT systems: Instrumentation Laboratory Hemochron Elite (Hmch), Medtronic HMS Plus (HMS), Abbott i-STAT, and Helena Abrazo. Subrange analyses were performed for low ACT values (results from T1, T5) and high ACT values (results from T2, T3, T4). Results: Within-system analysis showed strong linear correlation between paired measurements (R = 0.968-0.993). However, Hmch showed poorer reproducibility with highest proportion of values that exceed a difference of 10% and highest overall standard error of 74 seconds across the measurement range compared to that of the others (range 39-47 seconds, respectively). For inter-system comparison, using Hmch as reference, ACTs were strongly correlated as follows: HMS (R = 0.938), i-STAT (R = 0.911), and Abrazo (R = 0.911). Agreement analysis in the high ACT range showed HMS tended to have higher ACT values with +11% bias over Hmch, whereas i-STAT (–8% bias) and Abrazo (–13% bias) tended to underestimate. Post-protamine ACT results were dependent on device type where Hmch yielded highest post-protamine ACT (+13% higher than baseline) compared to –16% for HMS, –10% for iSTAT and 0% for Abrazo. Conclusions: Each device had individual reproducibility and biases, which may impact peri-operative heparin management. Careful validation must be undertaken when adopting a different method as decision limits would be affected. Clinicians should also be cautious using ACT as the only indicator for full heparin reversal.


2018 ◽  
Vol 35 (8) ◽  
pp. 621-626
Author(s):  
Elisabeth A.J. de Vos ◽  
Yolien J. Hagen ◽  
Michael I. Meesters ◽  
Nada Osmanovic ◽  
Christa Boer ◽  
...  

1992 ◽  
Vol 6 (3) ◽  
pp. 308-312 ◽  
Author(s):  
Jose M. den Hollander ◽  
Pim J. Hennis ◽  
Anton G.L. Burm ◽  
Arie A. Vletter ◽  
James G. Bovill

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2171-2171 ◽  
Author(s):  
Agata Anna Nowak ◽  
David NF Harris ◽  
Michael Laffan ◽  
Carolyn Millar

Abstract Abstract 2171 Post operative bleeding is a common complication of cardiac surgery; its aetiology may be multifactorial but is often attributed to platelet dysfunction. However, at present no reliable point of care test (POCT) is available for this and patients are often managed empirically; approximately 40% receive pooled platelet transfusions but many require re-sternotomy. An automated microchip flow chamber system that directly measures platelet-collagen interaction under shear (1500s−1) has recently been developed (T-TAS; Total Thrombus-formation system; Zakros, Fujmori Kogyto, Japan). We hypothesized that this could be developed as a POCT to assess platelet function under shear, allowing targeted and more rational use of blood products. We used this system to study 20 patients aged 19–72 years, before and after cardiac surgery. The T-TAS was used to determine the onset of occlusion (time to 10kPa, T10) and primary haemostatic potential (AUCend-area under pressure curve). Haematocrit (Hct), platelet count and von Willebrand factor (VWF) levels and thromboelastography (TEG) were measured at the corresponding time points. Surgery resulted in a significant increase in time to occlusion onset (T10) (p=0.006; n=20, Figure 1A). Similarly, the AUCend significantly decreased after surgery (p=0.001, n=19; Figure 1B) with the majority of cases (12 out of 20) failing to occlude within 30 minutes. The change in T10 inversely correlated with change in AUCend(r=-0.5, p=0.02). VWF is essential for platelet adhesion to collagen under high shear stress. Higher VWF levels appeared to be associated with lower T10, but this was not significant and only observed prior to surgery. Moreover, no significant correlation between the change in T10 or AUCend and changes in VWF pre- and post-surgery was observed. Surprisingly, pre and post-operative hematocrit were both negatively correlated with AUCend (r=-0.5, p=0.03, n=11 and r=-0.5, p=0.02,n=11 respectively). No correlation was observed between platelet count and the T-TAS parameters. However, the change in AUCend (but not T10) was shown to correlate with the change in platelet count before and after surgery (r = 0.58, p = 0.01). Finally, T10 and AUCend values were not significantly altered in patients given anti-platelet drugs: aspirin and/or clopidrogel. This implies that the T-TAS is sensitive to the initial adhesion of platelets to VWF-collagen rather than to platelet activation and aggregation. These data demonstrate that cardiac bypass surgery affects VWF mediated platelet adhesion to collagen under flow and this can be detected using a microchip flow chamber system. The lack of correlation with VWF levels and apparently paradoxical effect of haematocrit suggest that the dominant mechanism for the impaired postoperative haemostasis is a decline in platelet function and in particular a decrease in adhesive function. This is likely to result from altered exposure and/or function of GPIb resulting from surgery and cardio-pulmonary bypass. Current POCTs are largely insensitive to primary haemostatic mechanisms, while conventional laboratory measures of primary haemostasis are non-physiological, and require a considerable expertise and time. As expected, TEG gave similar values pre and post-surgery for all subjects, indicating that a flow system is required to adequately evaluate primary haemostasis. The advantages of this novel automated microchip flow chamber system are the small blood volume required and the rapidity of results. Our data suggest a place for this system in a point-of care setting, providing useful assessment of haemostatic status following surgery and with the potential to improve patient management. Further studies are warranted. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document